These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients. Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234 [TBL] [Abstract][Full Text] [Related]
11. High intercorrelations among urinary outputs of norepinephrine and its major metabolites. A replication in depressed patients and controls. Roy A; Guthrie S; Karoum F; Pickar D; Linnoila M Arch Gen Psychiatry; 1988 Feb; 45(2):158-61. PubMed ID: 3337613 [TBL] [Abstract][Full Text] [Related]
12. Biochemical correlates of affective disorders in children. Cytryn L; McKnew DH; Logue M; Desai RB Arch Gen Psychiatry; 1974 Nov; 31(5):659-61. PubMed ID: 4613320 [No Abstract] [Full Text] [Related]
13. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. Greenspan K; Schildkraut JJ; Gordon EK; Baer L; Aronoff MS; Durell J J Psychiatr Res; 1970 Feb; 7(3):171-83. PubMed ID: 5440858 [No Abstract] [Full Text] [Related]
14. Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: preliminary findings from studies of norepinephrine metabolism. Contributions to biochemistry. Schildkraut JJ Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):98-107. PubMed ID: 4438430 [No Abstract] [Full Text] [Related]
15. The effects of lithium on norepinephrine turnover and metabolism: basic and clinical studies. Schildkraut JJ J Nerv Ment Dis; 1974 May; 158(5):348-60. PubMed ID: 4823935 [No Abstract] [Full Text] [Related]
16. Relative activity of metabolic pathways for norepinephrine in endogenous depression. Roy A; Linnoila M; Karoum F; Pickar D Acta Psychiatr Scand; 1986 Jun; 73(6):624-8. PubMed ID: 3751666 [TBL] [Abstract][Full Text] [Related]
17. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878 [TBL] [Abstract][Full Text] [Related]
18. Catecholamine metabolism of manic-depressive illness. Takahashi R; Nagao Y; Tsuchiya K; Takamizawa M; Kobayashi T; Toru M; Kobayashi K; Kariya T J Psychiatr Res; 1968 Dec; 6(3):185-99. PubMed ID: 5731854 [No Abstract] [Full Text] [Related]
19. [Urinary excretion of MHPG in endogenous depression. Clinico-therapeutic index]. Roccatagliata G; Maini A; Bino G Minerva Psichiatr; 1981; 22(2):75-8. PubMed ID: 7266322 [No Abstract] [Full Text] [Related]
20. Depression: prognosis and drug treatment. Rose JT; Maxwell C Dis Nerv Syst; 1969 Mar; 30(3):186-8. PubMed ID: 4886702 [No Abstract] [Full Text] [Related] [Next] [New Search]